Neutropenia
175
15
16
114
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
30 trials with published results (17%)
Research Maturity
114 completed trials (65% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
5.1%
9 terminated out of 175 trials
92.7%
+6.1% vs benchmark
27%
47 trials in Phase 3/4
26%
30 of 114 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 114 completed trials
Clinical Trials (175)
Phase II Study of QLC2519 in Pediatric Solid Tumor Participants
Low-Dose Liposomal Amphotericin B for Invasive Fungal Infection Prophylaxis in Neutropenic Children
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome
Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia
Luspatercept for Clonal Cytopenias of Uncertain Significance
Predictive Score in Patients With Hematological Malignancies Colonized by Multidrug-resistant Enterobacteriaceae
Real-world Study on the Prevention of Neutropenia After Tumor Treatment With Mecapegfilgrastim Injection
Neutropenia With TNF-α Inhibitors
PC001- A Study to Evaluate the Usability of PointCheck
Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis
A Study of Mavorixafor in Participants With Congenital Neutropenia and Chronic Idiopathic Neutropenia Disorders
Letermovir Use in Heart Transplant Recipients
Serial Blood Count Study
Prospective Study Evaluate the Timing of Empirical Treatment for Carbapenem-resistant Bacterials (CROEAT Study)
A Study on the Use of Sulpegfilgrastim to Prevent the Incidence of Neutropenia With Infection in Newly Diagnosed Non-transplant Multiple Myeloma Patients
Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant
Study to Compare the Efficacy and Safety of F-627 and GRAN®